Loading…

Differences in Utilization of Drug-Eluting Stents by Race and Payer

Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervent...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2007-10, Vol.100 (8), p.1192-1198
Main Authors: Hannan, Edward L., PhD, Racz, Michael, PhD, Walford, Gary, MD, Clark, Luther T., MD, Holmes, David R., MD, King, Spencer B., MD, Sharma, Samin, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863
cites cdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863
container_end_page 1198
container_issue 8
container_start_page 1192
container_title The American journal of cardiology
container_volume 100
creator Hannan, Edward L., PhD
Racz, Michael, PhD
Walford, Gary, MD
Clark, Luther T., MD
Holmes, David R., MD
King, Spencer B., MD
Sharma, Samin, MD
description Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.
doi_str_mv 10.1016/j.amjcard.2007.05.039
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68351404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914907013215</els_id><sourcerecordid>1361791471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</originalsourceid><addsrcrecordid>eNqFklFrFDEQx4Mo9qx-BGUR7NtuJ5tNcnlR5FpboVCx9jnkspOSdS_bJrvC9dOb5RYLffEpBH7zz8wvQ8h7ChUFKk67yuw6a2Jb1QCyAl4BUy_Iiq6lKqmi7CVZAUBdKtqoI_ImpS5fKeXiNTmiUtXAuFiRzZl3DiMGi6nwobgdfe8fzeiHUAyuOIvTXXneT6MPd8XNiGFMxXZf_DQWCxPa4ofZY3xLXjnTJ3y3nMfk9tv5r81leXV98X3z9aq0jeRjWRsuuARmHbXCIRcGRY2KQb0VDFXDpeTOMedMA4YCKmBottJakXm5FuyYnBxy7-PwMGEa9c4ni31vAg5T0mLNOG2gyeDHZ2A3TDHk3nTNgAkpGp4hfoBsHFKK6PR99DsT95qCnhXrTi-K9axYA9dZca77sIRP2x22T1WL0wx8WgCTrOldNMH69MQpKhspZ-7LgcPs7I_HqJP180e0PqIddTv4_7by-VmC7X3w-dHfuMf0b2iqU61B38z7MK8DSKCsppz9BcyfrxE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230367645</pqid></control><display><type>article</type><title>Differences in Utilization of Drug-Eluting Stents by Race and Payer</title><source>Elsevier</source><creator>Hannan, Edward L., PhD ; Racz, Michael, PhD ; Walford, Gary, MD ; Clark, Luther T., MD ; Holmes, David R., MD ; King, Spencer B., MD ; Sharma, Samin, MD</creator><creatorcontrib>Hannan, Edward L., PhD ; Racz, Michael, PhD ; Walford, Gary, MD ; Clark, Luther T., MD ; Holmes, David R., MD ; King, Spencer B., MD ; Sharma, Samin, MD</creatorcontrib><description>Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2007.05.039</identifier><identifier>PMID: 17920356</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject><![CDATA[African Americans ; African Americans - statistics & numerical data ; Aged ; Aged, 80 and over ; Angioplasty, Balloon, Coronary - economics ; Angioplasty, Balloon, Coronary - utilization ; Biological and medical sciences ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Cardiovascular disease ; Coronary Stenosis - economics ; Coronary Stenosis - ethnology ; Coronary Stenosis - therapy ; Databases, Factual ; Drug Delivery Systems ; Drug-Eluting Stents - economics ; Drug-Eluting Stents - utilization ; Female ; Health Services Accessibility - economics ; Health Services Accessibility - statistics & numerical data ; Healthcare Disparities ; Hospitalization ; Humans ; Insurance, Health - statistics & numerical data ; Male ; Medicaid - statistics & numerical data ; Medical research ; Medical sciences ; Medicare - statistics & numerical data ; Middle Aged ; Minority Groups - statistics & numerical data ; New York - epidemiology ; Paclitaxel - administration & dosage ; Platelet Aggregation Inhibitors - administration & dosage ; Socioeconomic Factors ; Stents ; United States ; Vulnerable Populations - ethnology ; Vulnerable Populations - statistics & numerical data]]></subject><ispartof>The American journal of cardiology, 2007-10, Vol.100 (8), p.1192-1198</ispartof><rights>Elsevier Inc.</rights><rights>2007 Elsevier Inc.</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Oct 15, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</citedby><cites>FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19174776$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17920356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hannan, Edward L., PhD</creatorcontrib><creatorcontrib>Racz, Michael, PhD</creatorcontrib><creatorcontrib>Walford, Gary, MD</creatorcontrib><creatorcontrib>Clark, Luther T., MD</creatorcontrib><creatorcontrib>Holmes, David R., MD</creatorcontrib><creatorcontrib>King, Spencer B., MD</creatorcontrib><creatorcontrib>Sharma, Samin, MD</creatorcontrib><title>Differences in Utilization of Drug-Eluting Stents by Race and Payer</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.</description><subject>African Americans</subject><subject>African Americans - statistics &amp; numerical data</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioplasty, Balloon, Coronary - economics</subject><subject>Angioplasty, Balloon, Coronary - utilization</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Coronary Stenosis - economics</subject><subject>Coronary Stenosis - ethnology</subject><subject>Coronary Stenosis - therapy</subject><subject>Databases, Factual</subject><subject>Drug Delivery Systems</subject><subject>Drug-Eluting Stents - economics</subject><subject>Drug-Eluting Stents - utilization</subject><subject>Female</subject><subject>Health Services Accessibility - economics</subject><subject>Health Services Accessibility - statistics &amp; numerical data</subject><subject>Healthcare Disparities</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Insurance, Health - statistics &amp; numerical data</subject><subject>Male</subject><subject>Medicaid - statistics &amp; numerical data</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Medicare - statistics &amp; numerical data</subject><subject>Middle Aged</subject><subject>Minority Groups - statistics &amp; numerical data</subject><subject>New York - epidemiology</subject><subject>Paclitaxel - administration &amp; dosage</subject><subject>Platelet Aggregation Inhibitors - administration &amp; dosage</subject><subject>Socioeconomic Factors</subject><subject>Stents</subject><subject>United States</subject><subject>Vulnerable Populations - ethnology</subject><subject>Vulnerable Populations - statistics &amp; numerical data</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFklFrFDEQx4Mo9qx-BGUR7NtuJ5tNcnlR5FpboVCx9jnkspOSdS_bJrvC9dOb5RYLffEpBH7zz8wvQ8h7ChUFKk67yuw6a2Jb1QCyAl4BUy_Iiq6lKqmi7CVZAUBdKtqoI_ImpS5fKeXiNTmiUtXAuFiRzZl3DiMGi6nwobgdfe8fzeiHUAyuOIvTXXneT6MPd8XNiGFMxXZf_DQWCxPa4ofZY3xLXjnTJ3y3nMfk9tv5r81leXV98X3z9aq0jeRjWRsuuARmHbXCIRcGRY2KQb0VDFXDpeTOMedMA4YCKmBottJakXm5FuyYnBxy7-PwMGEa9c4ni31vAg5T0mLNOG2gyeDHZ2A3TDHk3nTNgAkpGp4hfoBsHFKK6PR99DsT95qCnhXrTi-K9axYA9dZca77sIRP2x22T1WL0wx8WgCTrOldNMH69MQpKhspZ-7LgcPs7I_HqJP180e0PqIddTv4_7by-VmC7X3w-dHfuMf0b2iqU61B38z7MK8DSKCsppz9BcyfrxE</recordid><startdate>20071015</startdate><enddate>20071015</enddate><creator>Hannan, Edward L., PhD</creator><creator>Racz, Michael, PhD</creator><creator>Walford, Gary, MD</creator><creator>Clark, Luther T., MD</creator><creator>Holmes, David R., MD</creator><creator>King, Spencer B., MD</creator><creator>Sharma, Samin, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20071015</creationdate><title>Differences in Utilization of Drug-Eluting Stents by Race and Payer</title><author>Hannan, Edward L., PhD ; Racz, Michael, PhD ; Walford, Gary, MD ; Clark, Luther T., MD ; Holmes, David R., MD ; King, Spencer B., MD ; Sharma, Samin, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>African Americans</topic><topic>African Americans - statistics &amp; numerical data</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioplasty, Balloon, Coronary - economics</topic><topic>Angioplasty, Balloon, Coronary - utilization</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Coronary Stenosis - economics</topic><topic>Coronary Stenosis - ethnology</topic><topic>Coronary Stenosis - therapy</topic><topic>Databases, Factual</topic><topic>Drug Delivery Systems</topic><topic>Drug-Eluting Stents - economics</topic><topic>Drug-Eluting Stents - utilization</topic><topic>Female</topic><topic>Health Services Accessibility - economics</topic><topic>Health Services Accessibility - statistics &amp; numerical data</topic><topic>Healthcare Disparities</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Insurance, Health - statistics &amp; numerical data</topic><topic>Male</topic><topic>Medicaid - statistics &amp; numerical data</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Medicare - statistics &amp; numerical data</topic><topic>Middle Aged</topic><topic>Minority Groups - statistics &amp; numerical data</topic><topic>New York - epidemiology</topic><topic>Paclitaxel - administration &amp; dosage</topic><topic>Platelet Aggregation Inhibitors - administration &amp; dosage</topic><topic>Socioeconomic Factors</topic><topic>Stents</topic><topic>United States</topic><topic>Vulnerable Populations - ethnology</topic><topic>Vulnerable Populations - statistics &amp; numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hannan, Edward L., PhD</creatorcontrib><creatorcontrib>Racz, Michael, PhD</creatorcontrib><creatorcontrib>Walford, Gary, MD</creatorcontrib><creatorcontrib>Clark, Luther T., MD</creatorcontrib><creatorcontrib>Holmes, David R., MD</creatorcontrib><creatorcontrib>King, Spencer B., MD</creatorcontrib><creatorcontrib>Sharma, Samin, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hannan, Edward L., PhD</au><au>Racz, Michael, PhD</au><au>Walford, Gary, MD</au><au>Clark, Luther T., MD</au><au>Holmes, David R., MD</au><au>King, Spencer B., MD</au><au>Sharma, Samin, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in Utilization of Drug-Eluting Stents by Race and Payer</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2007-10-15</date><risdate>2007</risdate><volume>100</volume><issue>8</issue><spage>1192</spage><epage>1198</epage><pages>1192-1198</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>17920356</pmid><doi>10.1016/j.amjcard.2007.05.039</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2007-10, Vol.100 (8), p.1192-1198
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_68351404
source Elsevier
subjects African Americans
African Americans - statistics & numerical data
Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary - economics
Angioplasty, Balloon, Coronary - utilization
Biological and medical sciences
Cardiology
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Coronary Stenosis - economics
Coronary Stenosis - ethnology
Coronary Stenosis - therapy
Databases, Factual
Drug Delivery Systems
Drug-Eluting Stents - economics
Drug-Eluting Stents - utilization
Female
Health Services Accessibility - economics
Health Services Accessibility - statistics & numerical data
Healthcare Disparities
Hospitalization
Humans
Insurance, Health - statistics & numerical data
Male
Medicaid - statistics & numerical data
Medical research
Medical sciences
Medicare - statistics & numerical data
Middle Aged
Minority Groups - statistics & numerical data
New York - epidemiology
Paclitaxel - administration & dosage
Platelet Aggregation Inhibitors - administration & dosage
Socioeconomic Factors
Stents
United States
Vulnerable Populations - ethnology
Vulnerable Populations - statistics & numerical data
title Differences in Utilization of Drug-Eluting Stents by Race and Payer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20Utilization%20of%20Drug-Eluting%20Stents%20by%20Race%20and%20Payer&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Hannan,%20Edward%20L.,%20PhD&rft.date=2007-10-15&rft.volume=100&rft.issue=8&rft.spage=1192&rft.epage=1198&rft.pages=1192-1198&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2007.05.039&rft_dat=%3Cproquest_cross%3E1361791471%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230367645&rft_id=info:pmid/17920356&rfr_iscdi=true